We are pleased to announce CHI’s Twelfth Annual High-Content Analysis meeting, the premier event showcasing the latest advancements in HCA applications and technologies. Over the years we have observed the technology mature and its adoption spread into many areas of compound screening/evaluation and functional analysis. The Twelfth Annual High-Content Analysis 2015 meeting will focus on the next steps of technology development, including new assays and probes, more advanced image analysis and data management, high-content screening of 3D models and ultra high-resolution imaging. This year, we will also co-locate CHI’s Inaugural Phenotypic Screening meeting, offering two tracks to choose from, expanded exhibit hall and an offering of user group meetings and dinner courses. The Phenotypic Screening meeting will address the advantages of phenotypic screening vs. target-based screening, and focus on assay development, selection of physiologically-relevant models and subsequent target identification, as well as case studies of phenotypic screens from leading pharma.
Full time graduate students and PhD Candidates are encouraged to apply for the High-Content Analysis or Phenotypic Screening student fellowship program.
Applications are due by November 14, 2014. Ten fellowship award winners will receive a poster presentation slot and up to $900 savings on their registration fee.
Anne E. Carpenter
Director, Imaging Platform
Broad Institute of Harvard and MIT
D. Lansing Taylor
Director, Drug Discovery Institute
University of Pittsburgh
Director, Molecular Biosensor and Imaging
Carnegie Mellon University
For exhibit & sponsorship information, please contact:
Manager, Business Development
For more details on the conference, please contact:
Executive Director, Conferences